Key result
Twenty PFA applications linked to ~110% higher first-pass mitral isthmus block success versus nine applications.
Why the study?
Data regarding the use of pulsed-field ablation for mitral isthmus ablation in non-paroxysmal AF were limited.
Does increasing pulsed-field ablation applications from 9 to 20 per series improve the rate of first-pass durable mitral isthmus block in patients with non-paroxysmal atrial fibrillation?
Does increasing pulsed-field ablation applications from 9 to 20 per series improve the rate of first-pass durable mitral isthmus block in patients with non-paroxysmal atrial fibrillation?
Increasing the number of pulsed-field ablation applications from 9 to 20 per series significantly improves the acute success rate of first-pass durable mitral isthmus block in patients with non-paroxysmal atrial fibrillation.
Introduction There is limited data regarding the use of pulsed‐field ablation (PFA) for mitral isthmus (MI) ablation in patients with non‐paroxysmal atrial fibrillation (AF). Our aim was to assess the acute efficacy of MI ablation using a pentaspline PFA catheter with two different ablation settings. Methods Patients with AF undergoing ablation were consecutively enrolled. All patients underwent pulmonary vein isolation and left atrial posterior wall ablation. MI ablation was performed in up to 4 series (9 PFA applications each) in Cohort A, or in up to 3 series (20 PFA applications each) in Cohort B. Each series was followed by a 20‐min observation period to verify the durability of the MI block. The primary endpoints were a first‐pass MI block and a final MI block after all ablation series. Results Between September 2024 and June 2025, 70 patients were enrolled: 30 in Cohort A and 40 in Cohort B. A first‐pass MI block was achieved in 10 (33.3%) patients in Cohort A and 28 (70%) patients in Cohort B ( p = 0.003). A final MI block was present in 27 (90%) and 35 (87.5%) patients in Cohort A and B, respectively ( p = 1.00). The median reconduction time was 6 min (IQR 2.8–9.4) in Cohort A and 5 min (IQR 2.6–8.7) in Cohort B. No major complications occurred. Conclusion Using series of 20 PFA applications increased the success rate of a first‐pass MI block to 70%. An observation period is recommended to verify the durability of MI block in PFA. Clinical Trial Registration: NCT06803238.
No takes yet. Share an insight, caveat, or question.
Hornof et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: